Gilberto Andrés Mejía

Gilberto Andrés Mejía

Auto-generated profile, based on publicly available information

Gilberto Andrés Mejía

Servicio de Cirugía de trasplantes, Unidad de Trasplantes, La Cardio, Fundación Cardioinfantil, Bogotá, D.C., Colombia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2006 in Transplantation Proceedings
Verified
Journal Article
Closed access
GMG.A. Mejia
G.A. Mejia
CACarlos Alvarez-Moreno
Carlos Alvarez-Moreno
HPH.H. Pulido
H.H. Pulido
BRB. Ramı́rez
B. Ramı́rez
CCC. Cardozo
C. Cardozo
AUA.M. Uribe
A.M. Uribe

1 March 2016 in Transplantation Proceedings
Verified
Journal Article
Closed access
GMG.A. Mejía
G.A. Mejía
COC. Olarte-Parra
C. Olarte-Parra
APA. Pedraza
A. Pedraza
JRJ.B. Rivera
J.B. Rivera
CBC.A. Benavides
C.A. Benavides

1 June 2006 in Transplantation Proceedings
Verified
Journal Article
Closed access
GMG.A. Mejia
G.A. Mejia
MBMIGUEL ANGEL GOMEZ BRAVO
MIGUEL ANGEL GOMEZ BRAVO
JSJ. Serrano
J. Serrano
IGI. Garcia
I. Garcia
MTM.J. Tamayo
M.J. Tamayo
ABA. Bernardos
A. Bernardos

1 April 2017 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
LSLuisa F. Santos
Luisa F. Santos
OBOscar Beltran
Oscar Beltran
MGMartin Garzon
Martin Garzon
JRJairo Rivera
Jairo Rivera
GMGilberto Mejia
Gilberto Mejia
AVAdriana Varon
Adriana Varon

26 September 2021 in Annals of Hepatology
Verified
Journal Article
Open access
MGMargarita Gutierrez
Margarita Gutierrez
LPLeonardo Pérez
Leonardo Pérez
OBOscar Beltrán
Oscar Beltrán
MGMartín Garzón
Martín Garzón
AAAlejandra Amaya
Alejandra Amaya
AVAdriana Varón
Adriana Varón
On January 30th of 2020, the WHO declared the COVID-19 outbreak a health emergency. In Colombia the first case was reported on March 6th of 2020. The disease has unfavorable outcomes and mortality in patients with high risk factors like solid-organ transplant recipients. In Colombia the data of the behavior disease in liver transplant patients are limited. To describe the prevalence, need of admission to hospital, complications and mortality of COVID-19 in liver transplant recipients. A descriptive study of case series was performed from March 1st of 2020 to January 31st of 2021 in liver transplant recipients at Fundación Cardioinfantil-IC in Bogotá, Colombia. An analysis of clinical variables, severity laboratories, imaging and clinical follow-up were performed. Qualitative variables were described in percentage and quantitative variables were applied to a normality test using Kolmogorov Smirnov and Shapiro Wilk and the results were expressed as medians and IRQ or means and SD. Out of 540 adults liver transplant recipients on Fundación Cardioinfantil-IC, 34 patients (6.2%) were diagnosed with Covid 19, median age 62 years (IQR: 26), 20 (58%) male, 13 (38.2%) were admitted to hospitalization, and 4 (11.7%) required ICU. More frequent symptoms were fever in 17/34 patients (50%), cough in 17/34 (50%) and dyspnea 10/34 (29.4%). Ten patients (29.4%) had pneumonia as radiographic findings. Four patients required mechanical ventilation. Complications like acute renal injury were found in 3 patients, 1 patient required renal replacement therapy and 1 patient had gastrointestinal bleeding. 3 patients died (8.8%) on average 14 days of hospital length in ICU. Although the group of liver transplant patients is considered to be at high risk for unfavorable outcomes in SARS COV2 infection, the data on mortality and complications were similar to the few data described in the literature.

1 January 2025 in IATREIA
Verified
Journal Article
Open access
PDF file
MRMaría Elena Ramos
María Elena Ramos
FCFundación Cardioinfantil
Fundación Cardioinfantil
CMCiro Andres Murcia
Ciro Andres Murcia
GMGilberto Mejía
Gilberto Mejía
La neumatosis quística intestinal es una afección poco común y, aunque se han propuesto diversas causas, las asociaciones con medicamentos y con el trasplante son sumamente infrecuentes. Reportamos un caso de neumatosis intestinal en una mujer que desarrolló la condición 20 días después de someterse a un trasplante hepático. Inicialmente se le atribuyó a una obstrucción intestinal causada por bridas, por lo que la paciente fue sometida a una laparotomía para liberarlas, sin embargo, la neumatosis persistió y la superficie intestinal afectada aumentó a pesar del tratamiento médico. Al mismo tiempo, la paciente experimentó una infección viral respiratoria con trombocitopenia secundaria, lo que llevó a la suspensión del micofenolato. Esta intervención resultó en una mejora tanto en los hallazgos de la neumatosis intestinal en las imágenes como en la sintomatología asociada. La perpetuación de esta condición en la paciente estuvo vinculada, probablemente, al uso del micofenolato, pues una vez suspendido el medicamento, la paciente presentó mejoría. La tomografía abdominal representa la técnica estándar de oro para el diagnóstico de la neumatosis intestinal, así como para la evaluación de su extensión y de sus complicaciones; por lo general, se presenta un desenlace favorable con tratamiento conservador, pues aquellos casos con requerimiento de manejo quirúrgico son de mal pronóstico.